183 related articles for article (PubMed ID: 29970901)
1. MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.
Wang QY; Zhou CX; Zhan MN; Tang J; Wang CL; Ma CN; He M; Chen GQ; He JR; Zhao Q
Cell Death Dis; 2018 Jul; 9(7):752. PubMed ID: 29970901
[TBL] [Abstract][Full Text] [Related]
2. MiR-630 suppresses breast cancer progression by targeting metadherin.
Zhou CX; Wang CL; Yu AL; Wang QY; Zhan MN; Tang J; Gong XF; Yin QQ; He M; He JR; Chen GQ; Zhao Q
Oncotarget; 2016 Jan; 7(2):1288-99. PubMed ID: 26595523
[TBL] [Abstract][Full Text] [Related]
3. miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9.
Gao JB; Zhu MN; Zhu XL
FEBS Open Bio; 2019 Nov; 9(11):1957-1967. PubMed ID: 31538724
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer.
Shibuya N; Kakeji Y; Shimono Y
Cancer Sci; 2020 Jun; 111(6):2093-2103. PubMed ID: 32307765
[TBL] [Abstract][Full Text] [Related]
5. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo.
Hu G; Chen D; Li X; Yang K; Wang H; Wu W
Cancer Biol Ther; 2010 Jul; 10(2):190-7. PubMed ID: 20505319
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.
Zhan MN; Yu XT; Tang J; Zhou CX; Wang CL; Yin QQ; Gong XF; He M; He JR; Chen GQ; Zhao Q
Cell Death Dis; 2017 Jan; 8(1):e2529. PubMed ID: 28055013
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.
Zhao Y; Pang W; Yang N; Hao L; Wang L
Int J Oncol; 2018 Dec; 53(6):2715-2726. PubMed ID: 30272349
[TBL] [Abstract][Full Text] [Related]
8. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
11. Facilitating colorectal cancer cell metastasis by targeted binding of long non-coding RNA ENSG00000231881 with miR-133b via VEGFC signaling pathway.
Zhou J; Zou Y; Hu G; Lin C; Guo Y; Gao K; Wu M
Biochem Biophys Res Commun; 2019 Jan; 509(1):1-7. PubMed ID: 30581003
[TBL] [Abstract][Full Text] [Related]
12. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
14. microRNA-133b represses the progression of lung cancer through inhibiting SOX9/β-catenin signaling pathway.
Liu S; Li S; Yu X; Wang Q; Sun H
Int J Clin Exp Pathol; 2020; 13(9):2270-2279. PubMed ID: 33042331
[TBL] [Abstract][Full Text] [Related]
15. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
[TBL] [Abstract][Full Text] [Related]
19. Endogenous human microRNAs that suppress breast cancer metastasis.
Tavazoie SF; Alarcón C; Oskarsson T; Padua D; Wang Q; Bos PD; Gerald WL; Massagué J
Nature; 2008 Jan; 451(7175):147-52. PubMed ID: 18185580
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.
Bhattacharjya S; Roy KS; Ganguly A; Sarkar S; Panda CK; Bhattacharyya D; Bhattacharyya NP; Roychoudhury S
Mol Cancer; 2015 Feb; 14():42. PubMed ID: 25743594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
